|
|
 |
|
 |
|
| 1 |
Bakht MK, Yamada Y, Ku SY, Venkadakrishnan VB, Korsen JA, Kalidindi TM, Mizuno K, Ahn SH, Seo JH, Garcia MM, Khani F, Elemento O, Long HW, Chaglassian A, Pillarsetty N, Lewis JS, Freedman M, Belanger AP, Nguyen QD, Beltran H. Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer. Nat Cancer. 2023 May;4(5):699-715. doi: 10.1038/s43018-023-00539-6. Epub 2023 Apr 10. PMID: 37038004
|
| 2 |
Zhao X, Sakamoto S, Wei J, Pae S, Saito S, Sazuka T, Imamura Y, Anzai N, Ichikawa T. Contribution of the L-Type Amino Acid Transporter Family in the Diagnosis and Treatment of Prostate Cancer. Int J Mol Sci. 2023 Mar 24;24(7):6178. doi: 10.3390/ijms24076178. PMID: 37047148
|
| 3 |
Venkadakrishnan VB, Yamada Y, Weng K, Idahor O, Beltran H. Significance of RB Loss in Unlocking Phenotypic Plasticity in Advanced Cancers. Mol Cancer Res. 2023 Jun 1;21(6):497-510. doi: 10.1158/1541-7786.MCR-23-0045. PMID: 37052520
|
| 4 |
Saito S, Sakamoto S, Higuchi K, Sato K, Zhao X, Wakai K, Kanesaka M, Kamada S, Takeuchi N, Sazuka T, Imamura Y, Anzai N, Ichikawa T, Kawakami E.
Machine-learning predicts time-series prognosis factors in metastatic prostate cancer patients treated with androgen deprivation therapy. Sci Rep. 2023 Apr 18;13(1):6325. doi: 10.1038/s41598-023-32987-6. PMID: 37072487
|
| 5 |
Komiya A, Kato M, Shibata H, Imamura Y, Sazuka T, Sakamoto S, Uchida N, Takayanagi Y, Nako Y, Tajima M, Hiraoka K, Ichikawa T, Kawai K. Results of lifestyle modification promotion and reproductive/general health check for male partners of couples seeking conception. Heliyon. 2023 Apr 5;9(4):e15203. doi: 10.1016/j.heliyon.2023.e15203. eCollection 2023 Apr.PMID: 37089364
|
| 6 |
Goto Y, Utsumi T, Maruo M, Kurozumi A, Noro T, Tanaka S, Sugawara S, Chiba K, Miyazaki K, Inoue A, Komaru A, Fukasawa S, Imamura Y, Sakamoto S, Nakatsu H, Suzuki H, Ichikawa T, Nagata M Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era. Int J Urol. 2023 Aug;30(8):659-665. doi: 10.1111/iju.15195. Epub 2023 May 2. PMID: 37130793
|
| 7 |
Goto Y, Kitamoto T, Tanaka S, Maruo M, Sugawara S, Chiba K, Miyazaki K, Inoue A, Nakai K, Tsurutani Y, Saito J, Omura M, Nishikawa T, Ichikawa T, Nagata M. Feasibility of single-port laparoscopic partial adrenalectomy with selective adrenal venous sampling and high-resolution ultrasound for unilateral aldosterone-producing adenomas. Surgery. 2023 Aug;174(2):234-240. doi: 10.1016/j.surg.2023.04.010. Epub 2023 May 13. PMID: 37188580
|
| 8 |
Ayumi Fujimoto, Shinichi Sakamoto, Takuro Horikoshi, Xue Zhao , Yasutaka Yamada, Junryo Rii, Nobuyoshi Takeuchi, Yusuke Imamura, Tomokazu Sazuka, Keisuke Matsusaka, Jun-Ichiro Ikeda, Tomohiko Ichikawa Tumor localization by Prostate Imaging and Reporting and Data System (PI-RADS) version 2.1 predicts prognosis of prostate cancer after radical prostatectomy Sci Rep. 2023 Jun 21;13(1):10079.doi: 10.1038/s41598-023-36685-1 PMID: 37344491
|
| 9 |
Sazuka T, Arai T, Sato H, Goto Y, Sakamoto S, Ichikawa T. Evaluating first-line immuno-oncology-based treatments for metastatic renal cell carcinoma in real world clinical practice using pre-treatment G8 scores. Int J Urol. 2023 Nov;30(11):1054-1056
doi: 10.1111/iju.15249. Epub 2023 Jul 11. PMID: 37431967
|
| 10 |
Hayato Ota, Hirokazu Sato, Shuji Mizumoto, Ken Wakai, Kei Yoneda, Kazuo Yamamoto, Hayao Nakanishi, Jun-Ichiro Ikeda, Shinichi Sakamoto, Tomohiko Ichikawa, Shuhei Yamada, Satoru Takahashi, Yuzuru Ikehara & Shoko Nishihara Switching mechanism from AR to EGFR signaling via 3-O-sulfated heparan sulfate in castration-resistant prostate cancer Sci Rep. 2023 Jul 18;13(1):11618.doi: 10.1038/s41598-023-38746-x. PMID: 37463954
|
| 11 |
Takayuki Arai, Tomokazu Sazuka, Ryuji Oka, Ryo Tsukamoto, Hiroaki Sato, Yusuke Goto, Yusuke Imamura, Shinichi Sakamoto, Tomohiko Ichikawa Investigation on the Usefulness of Photodynamic Diagnosis-assisted Targeted Bladder Biopsy: Japanese Real-world Study Anticancer Res. 2023 Aug;43(8):3615-3621.doi:10.21873/anticanres.16541. PMID: 37500129
|
| 12 |
Niino J, Goto Y, Sazuka T, Sato H, Arai T, Ichikawa T. Off-clamp robot-assisted partial nephrectomy for renal hilar tumors. Int J Urol. 2023 Dec;30(12):1194-1196. doi: 10.1111/iju.15282. Epub 2023 Aug 17. PMID: 37592434
|
| 13 |
Yamada Y, Sakamoto S, Sato K, Saito S, Kanesaka M, Rii J, Kurokawa K, Tachiwaki D, Fukui Y, Shibata H, Goto Y, Sazuka T, Imamura Y, Nakatsu H, Ichikawa T. Clinical utility of the prognostic nutritional index in patients with metastatic hormone-sensitive prostate cancer: A retrospective, multicenter, cohort study. Prostate. 2023 Dec;83(16):1610-1618. doi: 10.1002/pros.24619. Epub 2023 Sep 10. PMID: 37690087
|
| 14 |
Utsumi T, Suzuki H, Ishikawa H, Wakatsuki M, Okonogi N, Harada M, Ichikawa T, Akakura K, Murakami Y, Tsuji H, Yamada S. Identification of Early Biochemical Recurrence Predictors in High-Risk Prostate Cancer Patients Treated with Carbon-Ion Radiotherapy and Androgen Deprivation Therapy. Curr Oncol. 2023 Sep 27;30(10):8815-8825. doi: 10.3390/curroncol30100636. PMID: 37887536
|
| 15 |
Yasutaka Y. Varadha B V. Kei M. Martin B.Sheng-Y K. Maria M G.Himisha B. Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer Sci Transl Med. 2023 Nov 15;15(722):eadf6732.doi: 10.1126/scitranslmed.adf6732. Epub 2023 Nov 15. PMID: 37967200
|
| 16 |
Sazuka T, Matsushita Y, Sato H, Osawa T, Hinata N, Hatakeyama S, Numakura K, Ueda K, Kimura T, Takahashi M, Tanaka H, Kawasaki Y, Kurahashi T, Kato T, Fujita K, Miyake M, Kojima T, Kitamura H, Miyake H, Ichikawa T. Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study. Sci Rep. 2023 Nov 23;13(1):20629. doi: 10.1038/s41598-023-48087-4. PMID: 37996622
|
| 17 |
Fukui Y, Yamada Y, Sakamoto S, Horikoshi T, Zhao X, Sato K, Nanba S, Kubota Y, Kanesaka M, Fujimoto A, Shibata H, Goto Y, Sazuka T, Imamura Y, Uno T, Ichikawa T. Preoperative PI-RADS v2.1 Scoring System Improves Risk Classification in Patients Undergoing Radical Prostatectomy. Anticancer Res. 2023 Dec;43(12):5705-5712. doi: 10.21873/anticanres.16776. PMID: 38030183
|
| 18 |
Hagihara Y, Tomioka Y, Suetsugu T, Shinmura M, Misono S, Goto Y, Kikkawa N, Kato M, Inoue H, Mizuno K, Seki N. Identification of Tumor-Suppressive miR-139-3p-Regulated Genes: TRIP13 as a Therapeutic Target in Lung Adenocarcinoma. Cancers (Basel). 2023 Nov 24;15(23):5571. doi: 10.3390/cancers15235571. PMID: 38067275
|
| 19 |
Leung D, Castellani D, Nicoletti R, Dilme RV, Sierra JM, Serni S, Franzese C, Chiacchio G, Galosi AB, Mazzucchelli R, Palagonia E, Dell'Oglio P, Galfano A, Bocciardi AM, Zhao X, Ng CF, Lee HY, Sakamoto S, Vasdev N, Rivas JG, Campi R, Teoh JY. The Oncological and Functional Prognostic Value of Unconventional Histology of Prostate Cancer in Localized Disease Treated with Robotic Radical Prostatectomy: An International Multicenter 5-Year Cohort Study. Eur Urol Oncol. 2024 Jun;7(3):581-588.doi: 10.1016/j.euo.2023.12.006. Epub 2024 Jan 6.
|
| 20 |
Rii J, Sakamoto S, Mizokami A, Xu M, Fujimoto A, Saito S, Koike H, Tamura T, Arai T, Yamada Y, Goto Y, Sazuka T, Imamura Y, Suzuki K, Kanai Y, Anzai N, Ichikawa T. L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity. Cancer Sci. 2024Mar;115(3):937-953. doi: 10.1111/cas.16062. Epub 2024 Jan 7 PMID: 38186218
|
| 21 |
Maruo M, Goto Y, Miyazaki K, Inoue A, Kurokawa K, Enomoto A, Tanaka S, Katsura S, Sugawara S, Fuse M, Chiba K, Imamura Y, Sakamoto S, Nagata M, Ichikawa T. Novel nerve-sparing robot-assisted radical prostatectomy with endopelvic fascia preservation and long-term outcomes for a single surgeon. Sci Rep. 2024 Jan 9;14(1):926. doi: 10.1038/s41598-024-51598-3. PMID: 38195985
|
| 22 |
Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Bando Y, Nishiyama N, Kimura T, Yamashita S, Kitamura H, Miyake H; Japanese Urological Oncology Group. Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy. Int J Urol. 2024 May;31(5):526-533. doi: 10.1111/iju.15396. Epub 2024 Jan 19. PMID: 38240169
|
| 23 |
Kita Y, Otsuka H, Ito K, Hara T, Shimura S, Kawahara T, Kato M, Kanamaru S, Inoue K, Ito H, Igarashi A, Sazuka T, Takamatsu D, Hashimoto K, Abe T, Naito S, Matsui Y, Nishiyama H, Kitamura H, Kobayashi T; Japan Urological Oncology Group. Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan. Int J Urol. 2024 May;31(5):552-559. doi: 10.1111/iju.15411. Epub 2024 Feb 1. PMID: 38303567
|
| 24 |
Shinichi S. Keisuke A. Sangjon P. Xue Z. Kazuko S. Kodai S. Shinpei S. Yasutaka Y. Junryo R. Yusuke G. Tomokazu S. Yusuke I. Naohiko A. Koichiro A. Kazuto N. Tomohiko I.
Copy Number Gain in Androgen Receptors Predicts the Poor Prognosis in Japanese Castration-resistant Prostate Cancer Anticancer Res. 2024 Feb;44(2):639-647.doi: 10.21873/anticanres.16853. PMID: 38307556
|
| 25 |
Matsuda A, Taoka R, Miki J, Saito R, Fukuokaya W, Hatakeyama S, Kawahara T, Fujii Y, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Iio H, Yasue K, Abe T, Nakanishi S, Matsumura M, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Matsui Y; Japanese Urological Oncology Group. Prognostic impact of histological discordance between transurethral resection and radical cystectomy. BJU Int. 2024 Aug;134(2):207-218. doi: 10.1111/bju.16296. Epub 2024 Feb 12. PMID: 38344879
|
| 26 |
Shuhei Kamada MD, PhD, Shinichi Sakamoto MD, PhD, Ryo Kinoshita MD, PhD, Xue Zhao MD, Tomohiko Kamasako MD, PhD, Ryosuke Yamase MD, Rii Junryo MD, PhD, Shinpei Saito MD, PhD, Pae Sangjon MD, Akinori Takei MD, PhD, Yasutaka Yamada MD, PhD, Yusuke Goto MD, PhD, Yusuke Imamura MD, PhD, Taro Iguchi MD, PhD, Atsushi Mizokami MD, PhD, Hiroyoshi Suzuki MD, PhD, Koichiro Akakura MD, PhD, Tomohiko Ichikawa MD, PhD … See fewer authors Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix Prostate. 2024 May;84(7):636-643. doi: 10.1002/pros.24679. Epub 2024 Feb 27. PMID: 38413843
|
| 27 |
Ho Ming Chris Wong . Peter Ka-Fung Chiu. Ignacio Puche-Sanz. Zhao Xue. Dong-Ning Chen. Enrique Gomez-Gomez. Isabel Heidegger. Mona Kafka. Yong Wei. Shinichi Sakamoto. Anthony Chi Fai Ng. Lower baseline testosterone level is related to earlier development of castration resistance in metastatic prostate cancer: a multi-center cohort study Front Oncol. 2024 Feb 20:14:1321522. doi: 10.3389/fonc.2024.1321522. eCollection 2024 PMID:38444678
|
| 28 |
Goto Y. Editorial Comment on Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries .Int J Urol. 2024 Jun;31(6):597-598. doi: 10.1111/iju.15444. Epub 2024 Mar 8.PMID: 38454903
|
| 29 |
Kanaoka S, Okabe A, Kanesaka M, Rahmutulla B, Fukuyo M, Seki M, Hoshii T, Sato H, Imamura Y, Sakamoto S, Ichikawa T, Kaneda A. Chromatin activation with H3K36me2 and compartment shift in metastatic castration-resistant prostate cancer Cancer Lett. 2024 Apr 28;588:216815. doi: 10.1016/j.canlet.2024.216815. Epub 2024 Mar 13. PMID: 38490329
|
| 30 |
Goto Y. Editorial Comment on Prostate cancer and liquid biopsies: Clinical applications and challenges. Int J Urol. 2024 Jun;31(6):626-627. doi: 10.1111/iju.15456. Epub 2024 Mar 29. PMID: 38551310
|
|
 |
|
| 1 |
Hiroaki Sato, Tomokazu Sazuka, Ayumi Fujimoto, Sakurako Kagitani, Takayuki Arai, Yusuke Goto, Yusuke Imamura, Shinichi Sakamoto, Jun-Ichiro Ikeda, Tomohiko Ichikawa A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy
IJU Case Rep 2023 Mar 19;6(3):185-189.doi: 10.1002/iju5.12584. eCollection 2023 May. PMID: 37144081 PMCID: PMC10151202 DOI: 10.1002/iju5.12584
|
| 2 |
Sato H, Sazuka T, Fujimoto A, Kagitani S, Arai T, Goto Y, Imamura Y, Sakamoto S, Ikeda JI, Ichikawa T. A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy. IJU Case Rep. 2023 Mar 19;6(3):185-189. doi: 10.1002/iju5.12584. eCollection 2023 May. PMID: 37144081
|
| 3 |
Takeuchi N, Imamura Y, Ishiwata K, Kanesaka M, Goto Y, Sazuka T, Suzuki S, Koide H, Sakamoto S, Ichikawa T. Cushing's syndrome in pregnancy in which laparoscopic adrenalectomy was safely performed by a retroperitoneal approach. IJU Case Rep. 2023 Sep 10;6(6):415-418. doi: 10.1002/iju5.12637. eCollection 2023 Nov. PMID: 37928280
|
| 4 |
Tanaka S, Goto Y, Fujimoto A, Arai T, Sato H, Sazuka T, Imamura Y, Sakamoto S, Ikeda JI, Ichikawa T. A case of ipsilateral three simultaneous renal cell carcinomas with different histologic types. IJU Case Rep. 2023 Sep 4;6(6):410-414. doi: 10.1002/iju5.12636. eCollection 2023 Nov. PMID: 37928302
|
| 5 |
Arai Y, Goto Y, Sazuka T, Fujimoto A, Sato H, Imamura Y, Sakamoto S, Ota M, Ikeda JI, Ichikawa T. A case of bladder cancer after bilateral lung transplantation following bone marrow transplantation. JU Case Rep. 2023 Oct 4;6(6):471-474. doi: 10.1002/iju5.12651. eCollection 2023 Nov. PMID: 37928309
|
|
 |
|
| 1 |
Ikeyama S, Kanda S, Sakamoto S, Sakoda A, Miura K, Yoneda R, Nogi A, Ariji S, Shimoda M, Ono M, Kanda S, Yokoyama S, Takahashi K, Yokoyama Y, Hattori M.
A case of early onset cystinuria in a 4-month-old girl. CEN Case Rep. 2021 Oct 20. doi: 10.1007/s13730-021-00655-1. Online ahead of print. PMID: 34669168
|
|
|
|
|
|
|
|
|
|
|
|
|
